Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-105029
Filing Date
2024-12-03
Accepted
2024-12-03 16:00:22
Documents
2
Period of Report
2024-12-03

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0223428-6k_purplebio.htm 6-K 14198
2 PURPLE BIOTECH ANNOUNCES $2.8 MILLION REGISTERED DIRECT OFFERING OF AMERICAN DEP ea022342802ex99-1_purplebio.htm EX-99.1 15946
  Complete submission text file 0001213900-24-105029.txt   31421
Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104
Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121
PURPLE BIOTECH LTD. (Filer) CIK: 0001614744 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37643 | Film No.: 241522653
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)